PACAP modulates the consolidation and extinction of the contextual fear conditioning through NMDA receptors

Neurobiology of Learning and Memory

Volumn 118, Issue , 2015, Pages 120-124

  Schmidt, S D ^a   Myskiw, J C ^a,b   Furini, C R G ^a,b   Schmidt, B E ^a   Cavalcante, L E ^a   Izquierdo, I ^a,b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b National Research Council   (Brazil)

Author keywords

Consolidation; Contextual fear conditioning; Extinction; NMDA receptors; PACAP

Indexed keywords

GLUTAMIC ACID; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 38; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 6-38; SERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BASOLATERAL AMYGDALA; CONDITIONING; CONTEXTUAL FEAR CONDITIONING; CONTROLLED STUDY; HIPPOCAMPAL CA1 REGION; MALE; MEMORY CONSOLIDATION; MENTAL TASK; NEUROMODULATION; NONHUMAN; PROTEIN PROTEIN INTERACTION; RAT; REINFORCEMENT; TASK PERFORMANCE; ANIMAL; CONDITIONED REFLEX; DRUG EFFECTS; FEAR; MOTOR ACTIVITY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BASOLATERAL NUCLEAR COMPLEX; CA1 REGION, HIPPOCAMPAL; CONDITIONING, CLASSICAL; EXTINCTION, PSYCHOLOGICAL; FEAR; MALE; MOTOR ACTIVITY; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84919667840     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2014.11.014     Document Type: Article

References (50)

1. Almli L.M., Mercer K.B., Kerley K., Feng H., Bradley B., Conneely K.N., et al. ADCYAP1R1 genotype associates with post-traumatic stress symptoms in highly traumatized African-American females. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2013, 162B(3):262-272. 10.1002/ajmg.b.32145.
2. Anagnostaras S.G., Gale G.D., Fanselow M.S. Hippocampus and contextual fear conditioning: Recent controversies and advances. Hippocampus 2001, 11(1):8-17. 10.1002/1098-1063(2001) 11:1<8::AID-HIPO1015>3.0.CO;2-7.
3. Baldi E., Bucherelli C. Substantia nigra, nucleus basalis magnocellularis and basolateral amygdala roles in extinction of contextual fear conditioning in the rat. Neurobiology of Learning and Memory 2010, 94(2):199-205. 10.1016/j.nlm.2010.05.007.
4. Beckett W.S. Post-traumatic stress disorder. The New England Journal of Medicine 2002, 346(19):1495-1498. (author reply 1495-1498).
5. Brenneman D.E., Nicol T., Warren D., Bowers L.M. Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglial mitogen. Journal of Neuroscience Research 1990, 25(3):386-394. 10.1002/jnr.490250316.
6. Briscione M.A., Jovanovic T., Norrholm S.D. Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors. Frontiers in Psychiatry 2014, 5:88. 10.3389/fpsyt.2014.00088.
7. Burgos-Robles A., Vidal-Gonzalez I., Santini E., Quirk G.J. Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron 2007, 53(6):871-880. 10.1016/j.neuron.2007.02.021.
8. Costa L., Santangelo F., Li Volsi G., Ciranna L. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus. Hippocampus 2009, 19(1):99-109. 10.1002/hipo.20488.
9. De Carvalho Myskiw J., Benetti F., Izquierdo I. Behavioral tagging of extinction learning. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(3):1071-1076. 10.1073/pnas.1220875110.
10. De Carvalho Myskiw J., Furini C.R.G., Benetti F., Izquierdo I. Hippocampal molecular mechanisms involved in the enhancement of fear extinction caused by exposure to novelty. Proceedings of the National Academy of Sciences of the United States of America 2014, 111(12):4572-4577. 10.1073/pnas.1400423111.
11. Fahrenkrug J. Transmitter role of vasoactive intestinal peptide. Pharmacology & Toxicology 1993, 72(6):354-363.
12. Fahrenkrug J., Hannibal J. Neurotransmitters co-existing with VIP or PACAP. Peptides 2004, 25(3):393-401. 10.1016/j.peptides.2004.01.010.
13. Fiorenza N.G., Rosa J., Izquierdo I., Myskiw J.C. Modulation of the extinction of two different fear-motivated tasks in three distinct brain areas. Behavioural Brain Research 2012, 232(1):210-216. 10.1016/j.bbr.2012.04.015.
14. Fischer A., Radulovic M., Schrick C., Sananbenesi F., Godovac-Zimmermann J., Radulovic J. Hippocampal Mek/Erk signaling mediates extinction of contextual freezing behavior. Neurobiology of Learning and Memory 2007, 87(1):149-158. 10.1016/j.nlm.2006.08.003.
15. Fischer A., Sananbenesi F., Schrick C., Spiess J., Radulovic J. Distinct roles of hippocampal de novo protein synthesis and actin rearrangement in extinction of contextual fear. The Journal of Neuroscience. The Official Journal of the Society for Neuroscience 2004, 24(8):1962-1966. 10.1523/JNEUROSCI.5112-03.2004.
16. Hammack S.E., Cheung J., Rhodes K.M., Schutz K.C., Falls W.A., Braas K.M., et al. Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): Roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology 2009, 34(6):833-843. 10.1016/j.psyneuen.2008.12.013.
17. Hannibal J. Pituitary adenylate cyclase-activating peptide in the rat central nervous system: An immunohistochemical and in situ hybridization study. The Journal of Comparative Neurology 2002, 453(4):389-417. 10.1002/cne.10418.
18. Hannibal J., Møller M., Ottersen O.P., Fahrenkrug J. PACAP and glutamate are co-stored in the retinohypothalamic tract. The Journal of Comparative Neurology 2000, 418(2):147-155.
19. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., et al. International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacological Reviews 1998, 50(2):265-270.
20. Hashimoto H., Nogi H., Mori K., Ohishi H., Shigemoto R., Yamamoto K., et al. Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: An in situ hybridization study. The Journal of Comparative Neurology 1996, 371(4):567-577. 10.1002/(SICI)1096-9861(19960805)371:4<567::AID-CNE6>3.0.CO;2-2.
21. Izquierdo I., Bevilaqua L.R.M., Rossato J.I., Bonini J.S., Medina J.H., Cammarota M. Different molecular cascades in different sites of the brain control memory consolidation. Trends in Neurosciences 2006, 29(9):496-505. 10.1016/j.tins.2006.07.005.
22. Izquierdo I., Quillfeldt J.A., Zanatta M.S., Quevedo J., Schaeffer E., Schmitz P.K., et al. Sequential role of hippocampus and amygdala, entorhinal cortex and parietal cortex in formation and retrieval of memory for inhibitory avoidance in rats. The European Journal of Neuroscience 1997, 9(4):786-793.
23. Jaworski D.M., Proctor M.D. Developmental regulation of pituitary adenylate cyclase-activating polypeptide and PAC(1) receptor mRNA expression in the rat central nervous system. Brain Research. Developmental Brain Research 2000, 120(1):27-39.
24. Kim J.J., Fanselow M.S. Modality-specific retrograde amnesia of fear. Science (New York, N.Y.) 1992, 256(5057):675-677.
25. Laurent, V., & Westbrook, R. F. (2008). Distinct contributions of the basolateral amygdala and the medial prefrontal cortex to learning and relearning extinction of context conditioned fear. Learning & Memory (Cold Spring Harbor, N.Y.) (pp. 657-666). Vol. 15(9), doi: . doi:10.1101/lm.1080108.
26. Lee E.H., Seo S.R. Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases. BMB Reports 2014, 47(7):369-375.
27. Lioudyno M., Skoglösa Y., Takei N., Lindholm D. Pituitary adenylate cyclase-activating polypeptide (PACAP) protects dorsal root ganglion neurons from death and induces calcitonin gene-related peptide (CGRP) immunoreactivity in vitro. Journal of Neuroscience Research 1998, 51(2):243-256.
28. Macdonald D.S., Weerapura M., Beazely M.A., Martin L., Czerwinski W., Roder J.C., et al. Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires G alpha q, protein kinase C, and activation of Src. The Journal of Neuroscience. The Official Journal of the Society for Neuroscience 2005, 25(49):11374-11384. 10.1523/JNEUROSCI.3871-05.2005.
29. McGaugh J.L. Memory - A century of consolidation. Science 2000, 287:248-251.
30. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochemical and Biophysical Research Communications 1989, 164(1):567-574.
31. Miyata A., Jiang L., Dahl R.D., Kitada C., Kubo K., Fujino M., et al. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochemical and Biophysical Research Communications 1990, 170(2):643-648.
32. Myers K.M., Davis M. Mechanisms of fear extinction. Molecular Psychiatry 2007, 12(2):120-150. 10.1038/sj.mp.4001939.
33. Myskiw J.C., Izquierdo I., Furini C.R.G. Modulation of the extinction of fear learning. Brain Research Bulletin 2014, 105:61-69. 10.1016/j.brainresbull.2014.04.006.
34. Parsons M.W., Gold P.E. Glucose enhancement of memory in elderly humans: An inverted-U dose-response curve. Neurobiology of Aging 1992, 13(3):401-404.
35. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, San Diego.
36. Pincus D.W., DiCicco-Bloom E.M., Black I.B. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature 1990, 343(6258):564-567. 10.1038/343564a0.
37. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2008, 33(1):56-72. 10.1038/sj.npp.1301555.
38. Resch J.M., Albano R., Liu X., Hjelmhaug J., Lobner D., Baker D.A., et al. Augmented cystine-glutamate exchange by pituitary adenylate cyclase-activating polypeptide signaling via the VPAC1 receptor. Synapse (New York, N.Y.) 2014, 10.1002/syn.21772.
39. Ressler K.J., Mercer K.B., Bradley B., Jovanovic T., Mahan A., Kerley K., et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 2011, 470(7335):492-497. 10.1038/nature09856.
40. Sacchetti B., Lorenzini C.A., Baldi E., Bucherelli C., Roberto M., Tassoni G., et al. Pituitary adenylate cyclase-activating polypeptide hormone (PACAP) at very low dosages improves memory in the rat. Neurobiology of Learning and Memory 2001, 76(1):1-6. 10.1006/nlme.2001.4014.
41. Sananbenesi F., Fischer A., Wang X., Schrick C., Neve R., Radulovic J., et al. A hippocampal Cdk5 pathway regulates extinction of contextual fear. Nature Neuroscience 2007, 10(8):1012-1019. 10.1038/nn1943.
42. Sauvage M., Brabet P., Holsboer F., Bockaert J., Steckler T. Mild deficits in mice lacking pituitary adenylate cyclase-activating polypeptide receptor type 1 (PAC1) performing on memory tasks. Brain Research. Molecular Brain Research 2000, 84(1-2):79-89.
43. Sher L., Vilens A. Neurobiology of post-traumatic stress disorder 2010, Nova Biomedical, New York.
44. Szapiro G., Vianna M.R.M., McGaugh J.L., Medina J.H., Izquierdo I. The role of NMDA glutamate receptors, PKA, MAPK, and CAMKII in the hippocampus in extinction of conditioned fear. Hippocampus 2003, 13(1):53-58. 10.1002/hipo.10043.
45. Telegdy G., Kokavszky K. The action of pituitary adenylate cyclase activating polypeptide (PACAP) on passive avoidance learning. The role of transmitters. Brain Research 2000, 874(2):194-199.
46. Uddin M., Chang S.-C., Zhang C., Ressler K., Mercer K.B., Galea S., et al. Adcyap1r1 genotype, posttraumatic stress disorder, and depression among women exposed to childhood maltreatment. Depression and Anxiety 2013, 30(3):251-258. 10.1002/da.22037.
47. Vaudry D., Falluel-Morel A., Bourgault S., Basille M., Burel D., Wurtz O., et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacological Reviews 2009, 61(3):283-357. 10.1124/pr.109.001370.
48. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: From structure to functions. Pharmacological Reviews 2000, 52(2):269-324.
49. Wang L., Cao C., Wang R., Qing Y., Zhang J., Zhang X.Y. PAC1 receptor (ADCYAP1R1) genotype is associated with PTSD's emotional numbing symptoms in Chinese earthquake survivors. Journal of Affective Disorders 2013, 150(1):156-159. 10.1016/j.jad.2013.01.010.
50. Yaka R., He D.-Y., Phamluong K., Ron D. Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-D-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1. The Journal of Biological Chemistry 2003, 278(11):9630-9638. 10.1074/jbc.M209141200.